The collaboration will support the advancement of life sciences companies in Greater Philadelphia Hatch BioFund Management LLC (“Hatch BioFund”), an early- stage life sciences venture capital firm headquartered in the Philadelphia region, and Brandywine Realty Trust (“Brandywine”), one
Catharine and Rob Williams of Strafford are longtime supporters of the Foundation. The Hepatitis B Foundation announced today that Catharine and Rob Williams, who reside in Strafford, Pa., have been chosen to receive the Foundation’s Community Leadership
The Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC) honored Jim Greenwood, former Congressman and ex-CEO of BIO, at the organizations’ first Fireside Chat, held Oct. 17, by adding his portrait to their
Dr. Drew Weissman and Dr. Katalin Kariko The Baruch S. Blumberg Institute applauds Katalin Karikó, PhD, adjunct professor of Neurosurgery at The University of Pennsylvania’s Perelman School of Medicine, and Drew Weissman, MD, PhD, the Roberts Family
The National Institutes of Health Small Business Innovation Research (SBIR) Program has awarded a grant of more than $400,000 to researchers from Capital Health Cancer Center in Pennington, New Jersey, and JBS Scientific Inc. in Doylestown, Pennsylvania. The grant
Nicholas A. Meanwell, PhD, former pharmaceutical industry scientist and executive and now distinguished professor at the Baruch S. Blumberg Institute, has been selected as the recipient of the 2024 Antonin Holý Award by the International Society for
A special issue of a major drug development journal published recently honors Nicholas A. Meanwell, PhD, a former pharmaceutical industry scientist and executive who now is a distinguished professor at the Baruch S. Blumberg Institute. The journal’s
Robert Christmas, a longtime bank executive in the Philadelphia area, has been named chief operating officer of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC). Louis P. Kassa III, chief executive officer of the three nonprofit organizations and president of the PABC, said: “Bob has
Collaboration will help attract talent, new capital and resources to region’s biomedical research pipeline. The Wistar Institute has formed a new strategic collaboration with the Pennsylvania Biotechnology Center (PABC) and the Baruch S. Blumberg Institute to accelerate the advancement of “bench to bedside”
MERLIN Biotech CEO Randall N. Hyer delivers details – and a comprehensive strategic plan – for the company’s promising mRNA technology MERLIN Biotech, a spinout from the Baruch S. Blumberg Institute, presented its first asset last month
